Literature DB >> 30365620

Chronic migraine patients show cognitive impairment in an extended neuropsychological assessment.

Karen S Ferreira1, Caroliny T Teixeira1, Carolina Cáfaro1, Gabriela Z Oliver1, Gabriela L P Carvalho1, Larissa A S D Carvalho1, Brenda G Silva1, Fernanda B B Haes1, Marcelo C Ciciarelli1.   

Abstract

OBJECTIVES: The objective of the present study was to assess the presence of cognitive deficits in patients with chronic migraine, and to assess the main factors that trigger cognitive disorders, such as comorbidities or the use of medications.
METHODS: Chronic migraine and control groups were interviewed in a case-control study. The frequency and intensity of the headache, medication used and associated comorbidities were determined. All patients were submitted to an extended neuropsychological assessment.
RESULTS: The chronic migraine group (n = 30) had a worse performance in the Montreal Cognitive Assessment Test (p = 0.00), Verbal Fluency (p = 0.00), Stroop (p = 0.00), Clock Drawing Test (p = 0.00), Digit Span (p = 0.00) and Matrix Reasoning (p = 0.01). After statistical adjustment by linear regression, migraine continued to be the only relevant factor in the poorer performance in the Montreal Cognitive Assessment, Verbal Fluency, Clock Drawing and Stroop tests.
CONCLUSIONS: Patients with chronic migraine have cognitive deficits in multiple tasks, regardless of the presence of comorbidities or the use of medications.

Entities:  

Mesh:

Year:  2018        PMID: 30365620     DOI: 10.1590/0004-282X20180085

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  6 in total

Review 1.  [Cognition and driving ability in chronic pain syndrome].

Authors:  J Schmidt; M Weisbrod; M Fritz; S Aschenbrenner
Journal:  Nervenarzt       Date:  2022-09-28       Impact factor: 1.297

2.  Attention Impairment During the Interictal State in Migraineurs without Aura: A Cross-Sectional Study.

Authors:  Cheng Chen; Xin Dong; Ping Gu; Keyan Chen; Qi Wan; Haiyue Xie; Zhaochun Shi; Teng Wang
Journal:  J Pain Res       Date:  2021-10-06       Impact factor: 3.133

3.  Cognitive Dysfunction in Migraineurs.

Authors:  Tong Qin; Chunfu Chen
Journal:  Medicina (Kaunas)       Date:  2022-06-29       Impact factor: 2.948

4.  Association between migraine and cognitive impairment.

Authors:  Lihua Gu; Yanjuan Wang; Hao Shu
Journal:  J Headache Pain       Date:  2022-07-26       Impact factor: 8.588

5.  Preventive treatment can reverse cognitive impairment in chronic migraine.

Authors:  Cristina González-Mingot; Anna Gil-Sánchez; Marc Canudes-Solans; Silvia Peralta-Moncusi; Maria José Solana-Moga; Luis Brieva-Ruiz
Journal:  J Headache Pain       Date:  2022-09-15       Impact factor: 8.588

6.  Cognitive Function and White Matter Lesions in Medication-Overuse Headache.

Authors:  Yue Xiang; Shenggen Chen; Hanbin Lin; Wenting Xiong; Zhenyang Zheng
Journal:  J Pain Res       Date:  2021-06-17       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.